Open AccessThermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence
Author(s) -
Shamar Young,
Jafar Golzarian,
J. Kyle Anderson
Publication year - 2019
Publication title -
seminars in interventional radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.35
H-Index - 40
eISSN - 1098-8963
pISSN - 0739-9529
DOI - 10.1055/s-0039-1696650
Subject(s) - medicine , renal cell carcinoma , thermal ablation , ablation , carcinoma , radiology , surgery , urology , oncology
Renal cell carcinoma (RCC) is most commonly diagnosed at an early (T1a) stage and is typically amenable to several effective treatments. The current gold standard therapy is partial nephrectomy, given its decreased morbidity and similar oncologic outcomes when compared with radical nephrectomy. Thermal ablation is an evolving definitive therapy for T1a RCC which is even less invasive than partial nephrectomy. This article reviews the evidence for thermal ablation in the treatment of T1a RCC and compares outcomes of existing ablation modalities with surgical management.